A pipeline for identifying guide RNA sequences that promote RNA editing of nonsense mutations that cause inherited retinal diseases

Adenosine deaminases acting on RNA (ADARs) are endogenous enzymes catalyzing the deamination of adenosines to inosines, which are then read as guanosines during translation. This ability to recode makes ADAR an attractive therapeutic tool to edit genetic mutations and reprogram genetic information a...

Full description

Saved in:
Bibliographic Details
Main Authors: Nina Schneider (Author), Ricky Steinberg (Author), Amit Ben-David (Author), Johanna Valensi (Author), Galit David-Kadoch (Author), Zohar Rosenwasser (Author), Eyal Banin (Author), Erez Y. Levanon (Author), Dror Sharon (Author), Shay Ben-Aroya (Author)
Format: Book
Published: Elsevier, 2024-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_69692a161c7e4d13a0f741a54f85d38c
042 |a dc 
100 1 0 |a Nina Schneider  |e author 
700 1 0 |a Ricky Steinberg  |e author 
700 1 0 |a Amit Ben-David  |e author 
700 1 0 |a Johanna Valensi  |e author 
700 1 0 |a Galit David-Kadoch  |e author 
700 1 0 |a Zohar Rosenwasser  |e author 
700 1 0 |a Eyal Banin  |e author 
700 1 0 |a Erez Y. Levanon  |e author 
700 1 0 |a Dror Sharon  |e author 
700 1 0 |a Shay Ben-Aroya  |e author 
245 0 0 |a A pipeline for identifying guide RNA sequences that promote RNA editing of nonsense mutations that cause inherited retinal diseases 
260 |b Elsevier,   |c 2024-03-01T00:00:00Z. 
500 |a 2162-2531 
500 |a 10.1016/j.omtn.2024.102130 
520 |a Adenosine deaminases acting on RNA (ADARs) are endogenous enzymes catalyzing the deamination of adenosines to inosines, which are then read as guanosines during translation. This ability to recode makes ADAR an attractive therapeutic tool to edit genetic mutations and reprogram genetic information at the mRNA level. Using the endogenous ADARs and guiding them to a selected target has promising therapeutic potential. Indeed, different studies have reported several site-directed RNA-editing approaches for making targeted base changes in RNA molecules. The basic strategy has been to use guide RNAs (gRNAs) that hybridize and form a double-stranded RNA (dsRNA) structure with the desired RNA target because of ADAR activity in regions of dsRNA formation. Here we report on a novel pipeline for identifying disease-causing variants as candidates for RNA editing, using a yeast-based screening system to select efficient gRNAs for editing of nonsense mutations, and test them in a human cell line reporter system. We have used this pipeline to modify the sequence of transcripts carrying nonsense mutations that cause inherited retinal diseases in the FAM161A, KIZ, TRPM1, and USH2A genes. Our approach can serve as a basis for gene therapy intervention in knockin mouse models and ultimately in human patients. 
546 |a EN 
690 |a MT: RNA/DNA Editing 
690 |a RNA editing 
690 |a inherited retina diseases 
690 |a ADAR 
690 |a deaminization 
690 |a yeast 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Molecular Therapy: Nucleic Acids, Vol 35, Iss 1, Pp 102130- (2024) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2162253124000179 
787 0 |n https://doaj.org/toc/2162-2531 
856 4 1 |u https://doaj.org/article/69692a161c7e4d13a0f741a54f85d38c  |z Connect to this object online.